Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006 Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?

被引：2

作者：

Noel, Johanna ^{[1
]}

Huillard, Olivier ^{[1
]}

Goldwasser, Francois ^{[1
,2
,3
]}

机构：

[1] Hop Cochin Port Royal, AP HP, Med Oncol, Paris, France

[2] Canc Res Personalized Med CARPEM, Paris, France

[3] Univ Paris, Paris, France

来源：

EUROPEAN UROLOGY | 2021年 / 79卷 / 04期

关键词：

D O I：

10.1016/j.eururo.2021.01.013

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E112 / E112

页数：1

共 19 条

[1] Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser's Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?
Mori, Keiichiro
Schmidinger, Manuela
Egawa, Shin
Gust, Kilian M.
Shariat, Shahrokh F.
[J]. EUROPEAN UROLOGY, 2021, 79 (04) : E113 - E114
[2] Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Gao, Xiaoshuai
Chen, Guo
Wei, Xin
[J]. EUROPEAN UROLOGY, 2021, 80 (06) : E143 - E144
[3] Reply to Xiaoshuai Gao, Guo Chen, and Xin Wei's Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Pro- grammed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol 2021;79:783-92
Mori, Keiichiro
Schmidinger, Manuela
Egawa, Shin
Gust, Kilian M.
Shariat, Shahrokh F.
[J]. EUROPEAN UROLOGY, 2021, 80 (06) : E145 - E146
[4] The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis
Mori, Keiichiro
Abufaraj, Mohammad
Mostafaei, Hadi
Quhal, Fahad
Fajkovic, Harun
Remzi, Mesut
Karakiewicz, Pierre, I
Egawa, Shin
Schmidinger, Manuela
Shariat, Shahrokh F.
Gust, Kilian M.
[J]. EUROPEAN UROLOGY, 2021, 79 (06) : 783 - 792
[5] Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2020.04.038 Cytoreductive Nephrectomy: To Whom and When?
Mollica, Veronica
Rizzo, Alessandro
Massari, Francesco
[J]. EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (04): : 559 - 560
[6] Re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010
Kim, Sung Eun
Shin, Jae Il
Shoag, Jonathan Evan
[J]. EUROPEAN UROLOGY, 2021, 80 (01) : E14 - E14
[7] Re: Oscar Reig Torras, Akhilesh Mishra, Alana Christie, et al. Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.003
Wang, Zhan
Zhao, Yang
Zhang, Yushi
[J]. EUROPEAN UROLOGY, 2022, 81 (05) : E120 - E120
[8] Re: Christopher JD Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naive Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002
Vale, Claire
Fisher, David
Tierney, Jayne
White, Ian
Sydes, Matthew
Carpenter, James
[J]. EUROPEAN UROLOGY, 2018, 73 (03) : E49 - E50
[9] Re: Rohann JM Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.06.002
Montorsi, Francesco
Larcher, Alessandro
Capitanio, Umberto
[J]. EUROPEAN UROLOGY FOCUS, 2021, 7 (02): : 406 - 406
[10] Expression of Programmed Cell Death Ligand 1 as a Predictive Biomarker in Metastatic Urothelial Carcinoma Patients Treated with First-line Immune Checkpoint Inhibitors Versus Chemotherapy: A Systematic Review and Meta-analysis
Rizzo, Alessandro
Mollica, Veronica
Massari, Francesco
[J]. EUROPEAN UROLOGY FOCUS, 2022, 8 (01): : 152 - 159

← 1 2 →